comparemela.com

Latest Breaking News On - Element type - Page 4 : comparemela.com

Blue Cross of Minnesota, Davita launch VillageHealth kidney care program

Blue Cross and Blue Shield of Minnesota announced it will partner with DaVita Inc. to launch its integrated kidney care VillageHealth program in the Blue Cross Minnesota network. According to a press release, VillageHealth will allow Blue Cross members with chronic kidney disease or end-stage kidney disease to seek earlier and better care at a reduced cost. The new program promises improved

Rituximab safe, potentially effective adjuvant treatment for systemic sclerosis-PAH

B-cell depletion with rituximab was safe and may be a potentially effective treatment for patients with systemic sclerosis-associated pulmonary arterial hypertension, researchers reported. “This is the first placebo-controlled trial of a B-cell depleting therapy for PAH. While a negative study, the results were suggestive of therapeutic value. Selective immunotherapy, possibly guided by

Adjuvant pembrolizumab extends DFS in renal cell carcinoma

Adjuvant pembrolizumab extends DFS in renal cell carcinoma Source/Disclosures Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You ve successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Adjuvant pembrolizumab prolonged DFS compared with placebo for patients with renal cell carcinoma who underwent nephrectomy with or without resection of metastatic lesions, according to the agent’s manufacturer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.